Want to see UG full AI Analyst Report?
Top Page
United-Guardian
(NASDAQ:UG)
Select Model
Select Model
Rating:77Outperform
Price Target:
$8.00
▲(11.27% Upside)
Action:Reiterated
Date:08/18/26
The score is driven primarily by strong financial resilience (debt-free balance sheet and solid cash flow quality) and supportive shareholder returns (attractive dividend yield and a notable dividend increase). These positives are tempered by only modest and historically uneven operating performance and a mixed near-term technical picture despite longer-term moving-average support.
Positive Factors
Debt-Free Balance Sheet
Zero leverage materially limits financial risk, interest burden, and refinancing exposure. This gives United-Guardian flexibility to fund operations, withstand industry fluctuations, and preserve capital for product development or shareholder returns.
Negative Factors
Modest Revenue Growth
Low-single-digit growth indicates limited current expansion in the company’s specialty ingredients markets. Without stronger volume, pricing, or new-product contribution, revenue growth may constrain operating leverage and the pace of earnings improvement.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-Free Balance Sheet
Zero leverage materially limits financial risk, interest burden, and refinancing exposure. This gives United-Guardian flexibility to fund operations, withstand industry fluctuations, and preserve capital for product development or shareholder returns.
Read all positive factors
United-Guardian (UG) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$32.48M
Dividend Yield7.78%
Average Volume (3M)10.47K
Price to Earnings (P/E)13.1
Beta (1Y)0.22
Revenue Growth3.23%
EPS Growth-3.58%
CountryUS
Employees24
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.54
Shares Outstanding4,594,319
10 Day Avg. Volume7,837
30 Day Avg. Volume10,467
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)2.52
Price to Sales (P/S)2.68
P/FCF Ratio14.83
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
United-Guardian Business Overview & Revenue Model
Company Description
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industr...
How the Company Makes Money
United-Guardian makes money by manufacturing and selling specialty chemical ingredients to business customers, with revenue primarily driven by product sales rather than subscriptions or consumer retail. Key revenue streams include: (1) Personal c...
United-Guardian Financial Statement Overview
Summary
Income Statement
70
Positive
Balance Sheet
92
Very Positive
Cash Flow
86
Very Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.21M | 10.55M | 12.18M | 10.89M | 12.70M | 13.93M |
| Gross Profit | 5.15M | 5.03M | 6.46M | 5.41M | 6.70M | 8.18M |
| EBITDA | 2.98M | 2.75M | 4.20M | 3.36M | 4.98M | 6.02M |
| Net Income | 2.47M | 2.11M | 3.25M | 2.58M | 2.57M | 4.66M |
Balance Sheet | ||||||
| Total Assets | 13.59M | 13.11M | 13.80M | 12.92M | 10.64M | 12.24M |
| Cash, Cash Equivalents and Short-Term Investments | 8.93M | 8.57M | 9.40M | 9.09M | 6.48M | 8.17M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 1.96M | 1.88M | 1.91M | 1.53M | 1.37M | 2.42M |
| Stockholders Equity | 11.63M | 11.23M | 11.88M | 11.39M | 9.27M | 9.82M |
Cash Flow | ||||||
| Free Cash Flow | 3.33M | 1.91M | 3.03M | 2.98M | 2.45M | 5.20M |
| Operating Cash Flow | 3.37M | 1.97M | 3.47M | 3.14M | 2.53M | 5.31M |
| Investing Cash Flow | -545.34K | 175.34K | -7.08M | 4.73M | 897.56K | -183.47K |
| Financing Cash Flow | -2.30M | -2.77M | -2.76M | -459.39K | -3.12M | -5.19M |
United-Guardian Technical Analysis
Neutral
7.19
Price Trends
7.15
Negative
6.94
Positive
6.49
Positive
Market Momentum
-0.01
Positive
45.44
Neutral
12.72
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UG, the sentiment is Neutral. The current price of 7.19 is above the 20-day moving average (MA) of 7.16, above the 50-day MA of 7.15, and above the 200-day MA of 6.49, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 45.44 is Neutral, neither overbought nor oversold. The STOCH value of 12.72 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for UG.
United-Guardian Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | $32.48M | 13.09 | 22.24% | 6.56% | 3.23% | -3.58% | |
75 Outperform | $23.56B | 31.60 | 17.78% | 1.23% | 2.69% | 46.04% | |
69 Neutral | $613.67M | -56.47 | -6.99% | ― | -12.26% | -282.39% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
61 Neutral | $71.83B | 35.41 | 631.14% | 2.31% | 5.24% | -29.04% | |
57 Neutral | $11.40B | 19.56 | -1893.55% | 5.19% | -5.41% | -26.46% | |
33 Underperform | $46.97M | -5.42 | -83.49% | ― | -14.25% | 66.08% |
* Consumer Defensive Sector Average
UG
United-Guardian
7.07
-0.85
-10.74%
CHD
Church & Dwight
98.59
4.58
4.87%
CLX
Clorox
94.29
-24.79
-20.82%
CL
Colgate-Palmolive
90.09
8.46
10.37%
HNST
Honest Company
5.85
1.88
47.36%
GROV
Grove Collaborative Holdings
1.05
-0.49
-31.82%
United-Guardian Corporate Events
Business Operations and StrategyDividendsFinancial Disclosures
United-Guardian Boosts Dividend, Signals Ongoing Growth Confidence
Positive
Jul 17, 2026
On July 16, 2026, United-Guardian announced that its Board of Directors, at a meeting held on July 14, 2026, approved a cash dividend of $0.30 per share, payable on August 4, 2026, to shareholders of record as of July 28, 2026. This marks the 31st...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.